amotosalen has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiss, JE | 1 |
| Benjamin, RJ; Conlan, MG; Corash, L; Crookston, KP; Damon, L; George, J; Goodnough, LT; Hillyer, C; Kessler, C; Lin, JS; Lopez-Plaza, I; MacKenzie, M; McCrae, K; Menitove, JE; Mintz, PD; Neff, A; Rouault, C; Skikne, BS | 1 |
1 trial(s) available for amotosalen and Recrudescence
| Article | Year |
|---|---|
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Child; Disease-Free Survival; Double-Blind Method; Female; Furocoumarins; Humans; Infection Control; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Remission Induction; Time Factors; Ultraviolet Rays | 2006 |
1 other study(ies) available for amotosalen and Recrudescence
| Article | Year |
|---|---|
Randomized clinical trials in thrombotic thrombocytopenic purpura: where do we go from here?
Topics: Disease-Free Survival; Double-Blind Method; Female; Furocoumarins; Humans; Infection Control; Male; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Ultraviolet Rays | 2006 |